BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9442225)

  • 1. High-intensity lesion on T1-weighted MR images in neurofibromatosis type 1: a case of premalignant lesion.
    Miaux Y; Guermazi A; Cornu P; Mokhtari K; Singer B; Chiras J; Blanchet-Bardon C
    Acta Neurochir (Wien); 1997; 139(11):1085-7. PubMed ID: 9442225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous decrease of a pilocytic astrocytoma in neurofibromatosis type 1.
    Leisti EL; Pyhtinen J; Poyhonen M
    AJNR Am J Neuroradiol; 1996 Oct; 17(9):1691-4. PubMed ID: 8896624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous involution of pilocytic astrocytoma in a patient without neurofibromatosis type 1: case report.
    Gallucci M; Catalucci A; Scheithauer BW; Forbes GS
    Radiology; 2000 Jan; 214(1):223-6. PubMed ID: 10644128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cranial MR imaging in patients with von Recklinghausen's disease (neurofibromatosis type I).
    Hashimoto T; Tayama M; Miyazaki M; Kuroda Y; Hiura K; Hujino K; Yamashita K
    Neuropediatrics; 1990 Nov; 21(4):193-8. PubMed ID: 2127081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glioblastoma multiforme developing separately from the initial lesion 9 years after successful treatment for gliomatosis cerebri: a case report].
    Inoue T; Kanamori M; Sonoda Y; Watanabe M; Sasajima T; Kamisato N; Kumabe T; Tominaga T
    No Shinkei Geka; 2008 Aug; 36(8):709-15. PubMed ID: 18700534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
    Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
    Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
    Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
    Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliomas: correlation of magnetic susceptibility artifact with histologic grade.
    Bagley LJ; Grossman RI; Judy KD; Curtis M; Loevner LA; Polansky M; Detre J
    Radiology; 1997 Feb; 202(2):511-6. PubMed ID: 9015082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple glioblastomas: CT and MR features.
    Lafitte F; Morel-Precetti S; Martin-Duverneuil N; Guermazi A; Brunet E; Heran F; Chiras J
    Eur Radiol; 2001; 11(1):131-6. PubMed ID: 11194904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.
    Hakan T; Aker FV
    Neurol Neurochir Pol; 2008; 42(4):362-5. PubMed ID: 18975243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.
    Terada H; Barkovich AJ; Edwards MS; Ciricillo SM
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):755-60. PubMed ID: 8730197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma multiforme with diffusion-weighted magnetic resonance imaging characteristics mimicking primary brain lymphoma. Case report.
    Toh CH; Chen YL; Hsieh TC; Jung SM; Wong HF; Ng SH
    J Neurosurg; 2006 Jul; 105(1):132-5. PubMed ID: 16871888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous regression of multicentric pilocytic astrocytoma with CSF dissemination in an adult.
    Sakai K; Miyahara T; Tsutsumi K; Kaneko T; Fukushima M; Tanaka Y; Hongo K
    Brain Tumor Pathol; 2011 Apr; 28(2):151-6. PubMed ID: 21210237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI findings in children with neurofibromatosis type 1: a prospective study.
    Van Es S; North KN; McHugh K; De Silva M
    Pediatr Radiol; 1996 Jul; 26(7):478-87. PubMed ID: 8662066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearing enhancing brain lesion in a child with neurofibromatosis type I.
    Morris PW; Glasier CM; Smirniotopoulos JG; Allison JW
    Pediatr Radiol; 1997 Mar; 27(3):260-1. PubMed ID: 9126587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.
    DiPaolo DP; Zimmerman RA; Rorke LB; Zackai EH; Bilaniuk LT; Yachnis AT
    Radiology; 1995 Jun; 195(3):721-4. PubMed ID: 7754001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diffusion weighted MR: principles and clinical use in selected brain diseases].
    Nistri M; Mascalchi M; Moretti M; Tessa C; Politi LS; Orlandi I; Pellicanò G; Villari N
    Radiol Med; 2000 Dec; 100(6):470-9. PubMed ID: 11307509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole body MR imaging in neurofibromatosis type 1.
    Van Meerbeeck SF; Verstraete KL; Janssens S; Mortier G
    Eur J Radiol; 2009 Feb; 69(2):236-42. PubMed ID: 19091504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.